Marshall Wace North America’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$180K Buy
+65,276
New +$207K ﹤0.01% 1330
2019
Q2
– Sell
-4,560,794
Closed -$19.6M – 1097
2019
Q1
$19.6M Buy
+4,560,794
New +$20.9M 0.14% 145
2018
Q4
– Sell
-1,104,013
Closed -$5.05M – 1446
2018
Q3
$5.05M Sell
1,104,013
-1,862,799
-63% -$8.88M 0.03% 317
2018
Q2
$13.7M Sell
2,966,812
-185,877
-6% -$1.09M 0.08% 268
2018
Q1
$22.9M Buy
3,152,689
+622,917
+25% +$4.28M 0.11% 207
2017
Q4
$16.3M Buy
+2,529,772
New +$16.2M 0.09% 266
2017
Q3
– Sell
-3,563,786
Closed -$17.8M – 1210
2017
Q2
$17.8M Buy
+3,563,786
New +$20.3M 0.13% 202

Other funds holding ABEV

Marshall Wace North America's ABEV Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Ambev (ABEV) in Q3 2021: 65,276 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #1330 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in ABEV as recently as Q1 2019.

Marshall Wace North America first reported a position in ABEV in Q2 2017 and has held it in 7 quarters since. The position peaked at $22.9M in Q1 2018. 275 funds tracked by Wall St. Rank hold ABEV as of Q3 2021.

  • Marshall Wace North America held 65,276 shares of Ambev worth $180K as of Q3 2021.
  • Ambev was a new Marshall Wace North America position in Q3 2021.
  • Ambev made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1330 holding.
  • Marshall Wace North America first reported a position in Ambev in Q2 2017 and has held it in 7 quarters since.
  • Marshall Wace North America's Ambev position peaked at $22.9M in Q1 2018.
  • 275 funds tracked by Wall St. Rank held Ambev as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.